Ubs Oconnor LLC Ocular Therapeutix, Inc Transaction History

Ubs Oconnor LLC

$2.23 Billion
Q2 2025

A detailed history of Ubs Oconnor LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Ubs Oconnor LLC holds 120,000 shares of OCUL stock, worth $1.43 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

120,000

Holding current value

$1.43 Million

% of portfolio

0.05%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$6.02 - $9.46 $289,911 - $455,574	-48,158 Reduced 18.64%	210,205 $1.95 Million
Q1 2025 May 15, 2025	SELL	$5.93 - $9.08 $71,509 - $109,495	-12,059 Reduced 4.46%	258,363 $1.89 Million
Q4 2024 Feb 14, 2025	BUY	$8.33 - $11.47 $406,195 - $559,311	48,763 Added 22.0%	270,422 $2.31 Million
Q3 2024 Nov 14, 2024	SELL	$6.45 - $9.23 $109,650 - $156,910	-17,000 Reduced 7.12%	221,659 $1.93 Million
Q2 2024 Aug 14, 2024	BUY	$4.2 - $8.69 $210,340 - $435,203	50,081 Added 26.56%	238,659 $1.63 Million
Q1 2024 May 15, 2024	SELL	$3.85 - $10.93 $552,525 - $1.57 Million	-143,513 Reduced 43.21%	188,578 $1.72 Million
Q4 2023 Feb 14, 2024	SELL	$2.08 - $4.52 $20,841 - $45,290	-10,020 Reduced 2.93%	332,091 $1.48 Million
Q3 2023 Nov 14, 2023	BUY	$3.14 - $5.04 $125,600 - $201,600	40,000 Added 13.24%	342,111 $1.07 Million
Q2 2023 Aug 14, 2023	BUY	$4.6 - $7.64 $1.39 Million - $2.31 Million	302,111 New	302,111 $1.56 Billion
Q1 2023 May 15, 2023	BUY	$2.79 - $6.27 $159,959 - $359,477	57,333 Added 18.74%	363,286 $1.91 Million
Q4 2022 Feb 14, 2023	BUY	$2.61 - $4.41 $216,335 - $365,531	82,887 Added 37.16%	305,953 $0
Q3 2022 Nov 14, 2022	SELL	$4.09 - $6.5 $1.19 Million - $1.88 Million	-289,820 Reduced 56.51%	223,066 $926 Million
Q2 2022 Aug 12, 2022	BUY	$3.01 - $5.22 $640,786 - $1.11 Million	212,886 Added 70.96%	512,886 $2.06 Million
Q1 2022 May 16, 2022	BUY	$4.83 - $7.35 $1.45 Million - $2.21 Million	300,000 New	300,000 $1.49 Million

Others Institutions Holding OCUL

# of Institutions

205

Shares Held

137M

Call Options Held

743K

Put Options Held

321K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $919M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Account